Seamlessly bridging experimental chromatography, pharmacological validations, and commercial industrial batch manufacturing.
Global pharmaceutical formulators and nutraceutical innovators encounter steep hurdles in batch uniformity, chemical fingerprint variability, and escalating pilot-to-bulk scale risks. MedGence solves these friction points via vertically consolidated manufacturing clusters.
Our raw material qualification protocols target authentic regional cultivation centers (Daodi habitats). We monitor seasonal accumulation kinetics of alkaloids, polyphenols, and saponins to ensure harvested botanicals deliver the highest quantitative density before processing begins.
By leveraging dynamic countercurrent extraction lines, multi-column preparative chromatography, and low-temperature falling film evaporators, we prevent thermal degradation of delicate phytochemicals while maintaining extraction yields over 94.5%.
Our extraction methodologies remove pesticide residues, toxic heavy metals (Pb, As, Cd, Hg), polycyclic aromatic hydrocarbons (PAHs), and solvent residues through selective molecular distillation and supercritical CO2 extraction, meeting strict USP, EP, and ChP standards.
Turning empirical traditional usage into verifiable, peer-reviewed clinical assets through standardized pharmacology, cellular assays, and validated analytical methodologies.
We establish verified high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS), and gas chromatography (GC) fingerprints to assess assay purity, stability profiles, and exact chemical signatures.
Utilizing high-throughput enzyme kinetic models, receptor-binding assays, and primary cell culture lines to identify downstream pathways (such as anti-inflammatory, antioxidant, neuroprotective, or metabolic enzyme regulation) early in development.
Full acute toxicological evaluations, dose escalation ranges, maximum tolerated doses (MTD), sub-chronic rodent studies, Ames tests, and micronucleus genotoxicity assays to construct regulatory dossier packages that pass FDA and EMA filings.
Custom extraction yields, microencapsulation technologies, and solubility improvements designed to solve target formulation limits.
Free-flowing granulations, cold-water soluble botanical extracts, and microencapsulated carotenoids/polyphenols designed for direct tablet compression, hard two-piece capsules, and functional effervescent beverages without separation or sedimentation.
Batch-purified active pharmaceutical ingredients (APIs) with comprehensive drug master files (DMF), validated quantitative impurities profiling, stability validation, and full chromatographic documentation required for clinical human trials.
Decolored, deodorized botanical actives showing proven transdermal absorption kinetics. Target properties include melanogenesis inhibition, collagen synthesis up-regulation, and biological anti-glycation supported by quantitative in vitro tests.
Our systematic quality framework meets rigorous safety criteria across North America, Europe, Asia-Pacific, and Latin America, simplifying export processes and international customs release.
Macro/microscopic botanical identification confirmed via DNA barcoding, HPTLC multi-level fingerprinting, and chemical marker verification.
Traceability StandardRigorous multi-residue GC-MS/MS testing for 500+ agricultural pesticides, ICP-MS screening for heavy metals, and radiation testing.
Zero ContaminationIsocratic and gradient HPLC validation verifying primary biomarker ranges (e.g. Ginsenosides, Berberine, Curcuminoids, Baicalin) per batch.
Batch UniformitySupply of detailed Certificates of Analysis (COA), safety data sheets (SDS), non-GMO statements, BSE/TSE certificates, and process validation flows.
Audit-ReadyA transparent, milestone-driven development process from laboratory proof-of-concept to metric-ton commercial bulk deliveries.
Assaying raw materials from different harvest seasons and regional origins to isolate high-yield chemotypes and optimize raw material costs.
Milestone: Target Sourcing ReportDevelopment and validation of HPLC, GC, and HPTLC protocols with precision, repeatability, and recovery assays tested across pilot batches.
Milestone: QC Specification DossierFine-tuning extraction parameters (solvent ratios, temperature curves, elution chromatography cycles) to establish reliable commercial benchmarks.
Milestone: Process Validation ProtocolPerforming in vitro cellular bioassays alongside animal models for acute toxicity, systemic tolerance, and functional efficacy verification.
Milestone: Preclinical Safety PackageFacilitating small-group pilot trials for dietary supplements and compliant Phase 1-4 human clinical studies for botanical drug filings.
Milestone: Clinical Study Data FileFull-scale commercial production across cleanroom suites, packaging formats (liquids, extract powders, granules), and strictly private-label dispatch.
Milestone: Commercial Release BatchesHow automation, synthetic biology, and predictive bio-cheminformatics are transforming the global botanical ingredients sector.
Deep learning algorithms and computational molecular docking now predict multi-target interactions between complex herbal compounds and human disease receptors, reducing primary screening cycles from years down to weeks.
Transitioning from hydrocarbon extraction solvents toward deep eutectic solvents (NADES) and targeted enzyme-assisted extraction. This increases target active yield while lowering industrial energy footprints and environmental impact.
Global brand owners require comprehensive chain-of-custody data. Advanced genomic barcoding combined with immutable batch traceability provides buyers absolute certainty regarding botanical genus, species, and geographic authenticity.
Clear, direct technical answers addressing quality control, contract manufacturing parameters, and regulatory compliance.
Our scientific methodologies and industrial reliability support major pharmaceutical manufacturing brands, medical universities, and TCM hospital centers.
China Beijing Tongrentang Group
China Resources Sanjiu Medical
Sunflower Pharmaceutical Group
Livzon Pharmaceutical Group
Dihon Pharmaceutical Group
Golden Throat Holdings
Yangtzi River Pharmaceutical
Beihai Gofar Chuanshan Biological
Humanwell Healthcare Group
SCIMYTH Pharmaceutical Group
Shandong Hanfang Pharmaceutical
Shuguang Hospital (Shanghai)
Second Xiangya Hospital
First Hospital of Hunan Univ. of CMExplore our validated product lines and analytical study packages ready for immediate contract manufacturing scaling.
